Cargando…
Oral intake of phenylbutyrate with or without vitamin D(3) upregulates the cathelicidin LL-37 in human macrophages: a dose finding study for treatment of tuberculosis
BACKGROUND: We earlier showed that 4-phenylbutyrate (PB) can induce cathelicidin LL-37 expression synergistically with 1,25-dihydroxyvitamin D(3) in a lung epithelial cell line. We aimed to evaluate a therapeutic dose of PB alone or in combination with vitamin D(3) for induction of LL-37 expression...
Autores principales: | Mily, Akhirunnesa, Rekha, Rokeya Sultana, Kamal, S M Mostafa, Akhtar, Evana, Sarker, Protim, Rahim, Zeaur, Gudmundsson, Gudmundur H, Agerberth, Birgitta, Raqib, Rubhana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3637063/ https://www.ncbi.nlm.nih.gov/pubmed/23590701 http://dx.doi.org/10.1186/1471-2466-13-23 |
Ejemplares similares
-
Phenylbutyrate Counteracts Shigella Mediated Downregulation of Cathelicidin in Rabbit Lung and Intestinal Epithelia: A Potential Therapeutic Strategy
por: Sarker, Protim, et al.
Publicado: (2011) -
Ciprofloxacin Affects Host Cells by Suppressing Expression of the Endogenous Antimicrobial Peptides Cathelicidins and Beta-Defensin-3 in Colon Epithelia
por: Sarker, Protim, et al.
Publicado: (2014) -
Significant Effects of Oral Phenylbutyrate and Vitamin D3 Adjunctive Therapy in Pulmonary Tuberculosis: A Randomized Controlled Trial
por: Mily, Akhirunnesa, et al.
Publicado: (2015) -
Immune responses in the treatment of drug-sensitive pulmonary tuberculosis with phenylbutyrate and vitamin D(3) as host directed therapy
por: Rekha, Rokeya Sultana, et al.
Publicado: (2018) -
Efficacy of sodium butyrate adjunct therapy in shigellosis: a randomized, double-blind, placebo-controlled clinical trial
por: Raqib, Rubhana, et al.
Publicado: (2012)